Assign modules on offcanvas module position to make them visible in the sidebar.


nasal spray 0.05%, 10 ml

Dispensing conditions: NO PRESCRIPTION 

Category: Nasal preparations


  • acute rhinitis;

  • inflammation of the nasal sinuses;

  • to reduce swelling during diagnostic and therapeutic procedures.

dwldDownload instructions for use


10 ml of the product contains:

  • active substance  naphazoline nitrate - 5.0 mg;
  • excipient: boric acid, purified water

Pharmaceutical form

Nasal spray 0.05 %, 10 ml

Pharmacotherapeutic group

Respiratory system. Nasal preparations. Decongestants and other nasal medications for topical use. Simple sympathomimetics. Naphazoline.

ATC code R01AA08


  • acute rhinitis;
  • inflammation of the nasal sinuses;
  • to reduce swelling during diagnostic and therapeutic procedures.


  • hypersensitivity to the components of the product;
  • dry inflammation of the nasal mucosa;
  • children under 3 years of age;
  • hyperthyroidism;
  • chronic rhinitis;
  • diabetes mellitus;
  • dry rhinitis;
  • arterial hypertension;
  • coronary heart disease;
  • pheochromocytoma;
  • tachycardia;
  • severe eye diseases;
  • pronounced atherosclerosis;
  • closed angle glaucoma;
  • concomitant use of MAO inhibitors and up to 14 days after the end of their use.

Posology and method of administration

For children of 3 to 6 years of age, 1 to 2 injections into each nasal passage;

For children over 6 years of age and adolescents up to 15 years - 2 injections into each nasal passage.

Adverse reactions

Burning sensation and dryness in the nasal cavity, reactive hyperemia; with prolonged use - nasal mucous membrane swelling; allergic reactions, very rare - Quincke's edema.

If used for more than 1 week, it can be addictive.

Prolonged use may cause atrophic rhinitis.

Too frequent use can lead to dependence accompanied by intense mucosal edema occurring within a relatively short time after application. Prolonged use of the product may lead to disruption of the mucosal epithelium, inhibition of ciliary activity and lead to irreversible mucosal damage and development of dry rhinitis.


In case of an accidental overdose, stop using the product and consult a doctor immediately.

Use during pregnancy or breastfeeding

Use of the product during pregnancy and lactation is possible only under strict indications in cases when the expected therapeutic effect for the mother exceeds the potential risk of side effects in the fetus or child.

Pediatric population

Approved for children over 3 years of age.

Special warnings

Should be used with extreme caution in severe cardiovascular disease (hypertension, coronary heart disease), metabolic disorders (diabetes mellitus, hyperthyroidism), pheochromocytoma and concomitant treatment with MAO inhibitors and other hypertensive drugs.

Presentation and package

10 ml in polypropylene bottles with a spray lid and a protective cap. One bottle is with instruction for use in Kazakh and Russian language are placed in a carton pack.

Storage conditions

Store in a place protected from light, at a temperature of 180С to 250С.

Keep out of the reach of children.

Shelf life

3 years


"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan, tel.: (727) 253-03-88.

Marketing authorization holder

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan.

Name, address, contact information of the organization accepting claims (proposals) against quality of products from consumers in the territory of the Republic of Kazakhstan, which is responsible for post-authorization safety surveillance of the medicine:

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan,

Tel./Fax: (727) 253-07-07, 253-03-88, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Ask a question about this product: